It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Hemoglobin variability is known to increase cardiovascular mortality in chronic kidney disease, but the association of hemoglobin variability with the risk of cardiovascular disease (CVD) in the general population is yet unclear. This retrospective cohort study based on ‘the South Korean National Health Insurance Service database’ consisted of 198,347 adults who went through all three health examinations. Hemoglobin variability is defined as the average successive variability of three separate hemoglobin values from each health screening period. Participants were followed up for 6 years to determine the risk of coronary heart disease and stroke. We used multivariate Cox proportional hazards regression to examine the adjusted hazard ratios for CVD according to hemoglobin variability. Per 1 unit increase of hemoglobin variability, the risk for CVD (aHR 1.06, 95% CI 1.02–1.09) and stroke (aHR 1.08, 95% CI 1.03–1.13) increased significantly. The risk-increasing trend was preserved in the low-to-moderate risk group of CVDs (aHR 1.07, 95% CI 1.02–1.11). This result suggests that subjects with high hemoglobin variability who would otherwise be categorized as having low-to-moderate CVD risk may have higher risk of CVD than those with low hemoglobin variability.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Seoul National University College of Medicine, Department of Medicine, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
2 Seoul National University Graduate School, Department of Biomedical Sciences, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
3 Seoul National University Graduate School, Department of Biomedical Sciences, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); Seoul National University Hospital, Seoul National University College of Medicine, Department of Family Medicine, Seoul, South Korea (GRID:grid.412484.f) (ISNI:0000 0001 0302 820X)
4 Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Department of Family Medicine, Gwangmyeong-si, South Korea (GRID:grid.254224.7) (ISNI:0000 0001 0789 9563)
5 Seoul National University Hospital, Seoul National University College of Medicine, Department of Family Medicine, Seoul, South Korea (GRID:grid.412484.f) (ISNI:0000 0001 0302 820X)
6 Seoul National University Hospital, Home-Based Medical Care Team, Public Healthcare Center, Seoul, South Korea (GRID:grid.412484.f) (ISNI:0000 0001 0302 820X)
7 Gachon University Gil Medical Center, Department of Family Medicine, Incheon, South Korea (GRID:grid.411653.4) (ISNI:0000 0004 0647 2885)